We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nerve Stimulation Implant May Aid Depression

By HospiMedica staff writers
Posted on 04 Jan 2001
A pilot study involving patients with pharmacotherapy-resistant depression indicates that the use of vagus nerve stimulation (VNS) has the potential to bring about sustained improvement in such patients.

VNS therapy is delivered by an implantable medical device similar to a cardiac pacemaker called the NCP System, developed by Cyberonics, Inc. More...
(Houston, TX, USA). A stopwatch-sized generator is implanted in the left chest and a nerve stimulation electrode is attached to the vagus nerve in the neck, typically on an outpatient basis. Using an external programmer, a doctor can set or reset the stimulation parameters of the device. The system delivers preprogrammed intermittent electrical pulses to the vagus nerve 24 hours a day. The system has been approved by the U.S. Food and Drug Administration (FDA) for adjunctive therapy for the treatment of medically refractory partial onset seizures in adults and adolescents over 12. The system is not yet authorized for the treatment of depression.

A pivotal study involving 102 patients at 20 U.S. sites is now under way. In addition, enrollment has begun for a multicenter European study, beginning at Beaumont Hospital in Dublin (Ireland), an important neuroscience center in Ireland. "We are extremely excited to begin the clinical trial, as VNS therapy represents a new milestone in the treatment of patients with depression,” said Veronica O'Keane, M.D., psychiatrist at Beaumont Hospital and principal investigator in the European study.



Related Links:
Cyberonics

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.